Company: ANTX
Filing Date: 2025-03-25
Form Type: 10-K
Source: 0000950170-25-044366
Chunk: 39

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-03-25
Form: 10-K
Item: Item 16
Chunk 39
---
, Inc. 2017 Equity Incentive Plan, as amended.
     
    S-1
     
    333-263295
     
    10.1
     
    March 4, 2022

    10.2#
     
    Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise and Early Exercise Stock Purchase Agreement under the AN2 Therapeutics, Inc. 2017 Equity Incentive Plan.
     
    S-1
     
    333-263295
     
    10.2
     
    March 4, 2022

    10.3#
     
    AN2 Therapeutics, Inc. 2022 Equity Incentive Plan
     
    10-K
     
    001-41331
     
    10.3
     
    March 29, 2024

    10.4#
     
    Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.
     
    S-1
     
    333-263295
     
    10.4
     
    March 4, 2022

    10.5#
     
    Form of Restricted Stock Unit Grant Notice and Award Agreement under the AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.
     
    10-K
     
    001-41331
     
    10.5
     
    March 29, 2024

    10.6#
     
    AN2 Therapeutics, Inc 1022 Employee Stock Purchase Plan.
     
    10-K
     
    001-41331
     
    10.6
     
    March 29, 2024

    10.7#
     
    AN2 Therapeutics, Inc. 2022 Non-Employee Director Compensation Policy.
     
    S-1
     
    333-263295
     
    10.7
     
    March 4, 2022

    10.8#
     
    AN2 Therapeutics, Inc. Officer Severance Plan.
     
    S-1
     
    333-263295
     
    10.8
     
    March 4,